Dr.Reddy's Laboratories Ltd represents the values of integrity, excellence, and innovation. With a strong corporate philosophy focused on making quality healthcare accessible to all, the company strives to improve the lives of patients globally. Dr.Reddy's Laboratories is committed to conducting business in an ethical and responsible manner, prioritizing patient safety, and adhering to the highest standards of quality in pharmaceutical products. Through continuous research and development, they aim to bring innovative solutions to healthcare challenges and contribute towards a healthier society.

Dr.Reddy's Laboratories Ltd is primarily present in several countries and regions. The company has a widespread global presence and operates in various key markets. Some of the countries and regions where Dr.Reddy's Laboratories Ltd has a significant presence include India, the United States, Europe, Russia, China, and many others. With its extensive reach, Dr.Reddy's Laboratories Ltd has established a strong foothold in the global pharmaceutical industry, catering to diverse markets and delivering innovative healthcare solutions around the world.

Dr.Reddy's Laboratories Ltd, a leading pharmaceutical company, has achieved several remarkable milestones. Firstly, the company successfully launched various generic drugs, consolidating its position in the global market. Additionally, Dr.Reddy's Laboratories Ltd established itself as a pioneer in drug innovation, securing numerous product patents worldwide. Moreover, the company received several prestigious awards, applauding its excellence in research and development. Dr.Reddy's Laboratories Ltd expanded its global footprint by entering into strategic alliances and acquisitions, fostering international growth. Lastly, the company consistently focuses on improving patient healthcare outcomes, ensuring affordable and accessible medication options worldwide. Overall, Dr.Reddy's Laboratories Ltd demonstrates an impressive track record of accomplishments in the pharmaceutical industry.

Dr. Reddy's Laboratories Ltd is a renowned Indian pharmaceutical company, founded in 1984 by Dr. Kallam Anji Reddy. The company has grown into one of the leading integrated pharmaceutical firms globally. Dr. Reddy's Laboratories Ltd specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generic drugs, branded generics, over-the-counter medications, and active pharmaceutical ingredients (APIs). With a strong focus on research and development, the company has established a significant presence in numerous markets worldwide. Dr. Reddy's Laboratories Ltd has received several accolades for its innovative and cost-effective healthcare solutions, contributing to the well-being of individuals across the globe.

Some of the main competitors of Dr. Reddy's Laboratories Ltd in the market include Sun Pharmaceutical Industries Ltd, Lupin Limited, Cipla Ltd, and Torrent Pharmaceuticals Ltd. These companies are also prominent players in the pharmaceutical industry and compete with Dr. Reddy's Laboratories Ltd in the production and distribution of generic and branded drugs.

Dr.Reddy's Laboratories Ltd is primarily active in the pharmaceutical industry.

Dr. Reddy's Laboratories Ltd operates as a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company's business model revolves around the development and commercialization of generic drugs, active pharmaceutical ingredients (APIs), and differentiated formulations. Dr. Reddy's Laboratories leverages its expertise in drug discovery, process chemistry, and formulation technologies to provide affordable and high-quality healthcare solutions to patients worldwide. With a strong focus on research and development, strategic partnerships, and global market presence, Dr. Reddy's Laboratories continues to contribute to the healthcare industry by delivering innovative and cost-effective pharmaceutical products.

مُعامل القيمة السوقية إلى الأرباح لـ Dr Reddy's Laboratories هو ١٩٫٨٨.

مُعامِل القيمة إلى المبيعات Dr Reddy's Laboratories هو ٣٫٩٦.

نقاط جودة AlleAktien لـ Dr Reddy's Laboratories هي 9/10.

Dr Reddy's Laboratories الإيرادات هي ٢٨٠٫١١ مليارات INR.

صافي الربح Dr Reddy's Laboratories هو ٥٥٫٧٨ مليارات INR.

Dr. Reddy's Laboratories Ltd. is a multinational pharmaceutical company based in Hyderabad, India. The company specializes in the manufacturing, development, marketing, and distribution of generics, biosimilars, and innovative pharmaceutical products for global markets. The core business of Dr. Reddy's is the production of generics, which are affordable, imitation versions of original drugs. They serve as cost-effective alternatives to expensive branded medications in many countries. The company offers a wide range of generic products and caters to various therapeutic areas such as gastroenterology, cardiology, oncology, neurology, rheumatology, dermatology, and more. Another important segment of the business is the development and marketing of biosimilars. Biosimilars are biologically produced drugs that resemble the composition, effectiveness, and safety of the original product. Dr. Reddy's has a strong pipeline of biosimilars for various diseases such as cancer, autoimmune diseases, and diabetes. The company also heavily invests in innovation. It has developed a range of innovative products that can be used to treat diseases like depression, schizophrenia, and Parkinson's. This includes a long-acting atypical antipsychotic, a low-dose antidepressant, and a neuroprotective drug. In addition to its core business segments, Dr. Reddy's also participates in the marketing of active pharmaceutical ingredients (APIs). The company distributes GMP-certified API products to customers worldwide. The product range includes chemical and biological agents used in various therapeutic areas. Dr. Reddy's products are available in over 100 countries worldwide. The company is committed to meeting the ongoing need for affordable medications while ensuring that patients receive high-quality products. It employs over 20,000 employees globally and collaborates with numerous partners and domestic pharmaceutical companies to achieve its vision. Overall, the activities of Dr. Reddy's Laboratories Ltd. are diverse, encompassing the production and distribution of generics, biosimilars, innovative pharmaceutical products, and APIs. The company has a strong global presence and plays a leading role in the pharmaceutical industry. With its extensive experience and commitment to providing affordable medications, Dr. Reddy's is well-positioned to promote growth in the pharmaceutical industry and the well-being of patients worldwide.

يوزع Dr Reddy's Laboratories أرباحًا قدرها ٣٠٫٠٠ INR من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Dr Reddy's Laboratories في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـDr Reddy's Laboratories هو INE089A01023.

رمز WKN لـ Dr Reddy's Laboratories هو 659157.

الرمز المُختصر لـ Dr Reddy's Laboratories هو DRREDDY.NS.

خلال آخر 12 شهراً، دفعت Dr Reddy's Laboratories توزيعات أرباح بقيمة ٤٠٫٠٠ INR . وهذا يعادل عائد توزيعات أرباح يقارب ٠٫٦٠ %. ومن المتوقع أن تدفع Dr Reddy's Laboratories خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٤٣٫٥٤ INR.

نسبة توزيعات الأرباح الحالية لـ Dr Reddy's Laboratories هي ٠٫٦٠ %.

Dr Reddy's Laboratories يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أغسطس, أغسطس, أغسطس, أغسطس.

Dr Reddy's Laboratories دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٤٣٫٥٤ INR. وهذا يعادل عائد توزيعات أرباح قدره ٠٫٦٥ %.

Dr Reddy's Laboratories يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٤٠ INR من Dr Reddy's Laboratories المُعلن عنها في ٢٨‏/٨‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ١٦‏/٧‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٨‏/٨‏/٢٠٢٤.

في العام 2023، وزعت Dr Reddy's Laboratories ٤٠ INR كأرباح أسهم.

يتم توزيع أرباح Dr Reddy's Laboratories بالعملة INR.